Precision Nanomedicine to Target the Most Challenging Tumors
ISS National Lab‑enabled research supports next‑generation chemotherapy and immunotherapy development KENNEDY SPACE CENTER, Fla., April 9, 2026 /PRNewswire/ -- Eascra Biotech is leveraging the International Space Station (ISS) National Laboratory to advance the next generation of targeted...
View original →